Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Nils Ostendorf

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 18, 2016
[Flow-cytometric immunophenotyping in clinical diagnostics]Benjamin Nils Ostendorf, Leo Hansmann, Wolf-Dieter Ludwig, et al.
Immunology Letters|October 15, 2015
Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinomaAnne Flörcken, Anna Takvorian, Anju Singh, et al.
Springerplus|July 15, 2014
Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case reportBenjamin Nils Ostendorf, Christian Friedrich Jehn, Lam Giang Vuong, et al.
BMC Cancer|March 20, 2026
PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancerRobert Siegel, Luca Dittrich, Julius Plewe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|October 18, 2016
[Flow-cytometric immunophenotyping in clinical diagnostics]Benjamin Nils Ostendorf, Leo Hansmann, Wolf-Dieter Ludwig, et al.
Immunology Letters|October 15, 2015
Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinomaAnne Flörcken, Anna Takvorian, Anju Singh, et al.
Springerplus|July 15, 2014
Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case reportBenjamin Nils Ostendorf, Christian Friedrich Jehn, Lam Giang Vuong, et al.
BMC Cancer|March 20, 2026
PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancerRobert Siegel, Luca Dittrich, Julius Plewe, et al.
Pageof 1